Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience.
Beaunoyer
M
M
Unité de Transplantation, Hôpital Notre-Dame du Centre Hospitalier de l'Université de Montréal, 1560 Severbrooke Est, Montréal, Québec, Canada H2L HM1.
Busque
S
S
St-Louis
G
G
Smeesters
C
C
Pâquet
M
M
Lallier
M
M
Fugère
J
J
Girardin
C
C
Hébert
M-J
MJ
Daloze
P
P
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D002102:Cadaver; D002648:Child; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011241:Prednisone / Q000009:adverse effects*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors
D000305:Adrenal Cortex Hormones; D009173:Mycophenolic Acid; D011241:Prednisone; D016559:Tacrolimus